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A New Gold Standard for Varicose Vein Treatment?The current principles of surgical treatment of varicose veins
were established at the beginning of the 20th century by
Perthes, Keller, Mayo, Bacbock and others. They include
ligation of the incompetent sapheno-femoral or sapheno-
popliteal junction, stripping of the refluxing saphenous vein
and phlebectomy of varicose branches. These principles
have been increasingly challenged since the advent of
thermal ablation by laser or radio-frequency around the turn
of the millennium. Furthermore, sclerotherapy has gained
renewed interest due to improved results by ultrasound
guidance and the use of foam instead of liquid agents.
Two randomised controlled trials (RCTs) comparing
endovenous laser ablation (EVLA) of refluxing saphenous
veins with surgical high ligation and stripping were pub-
lished by Rasmussen et al.1 and by Darwood et al.2
Furthermore, Disselhoff et al.3 published an RCT comparing
EVLA with cryosurgery. All studies used laser light with
a wavelength of 980 nm. In all trials, abolition of reflux was
marginally superior after EVLA, but the differences were
not significant. Improvement of symptoms according to
AVVSS (the Aberdeen Varicose Vein Symptom Severity
Score) or VCSS (the Venous Clinical Severity Score) was
similar after EVLA and surgery. Return to normal activities
was earlier after EVLA than after surgery, according to the
Darwood and Disselhof trials, but not in the Rasmussen
study. However, all trials found a tendency towards less
pain and bruising after EVLA.
Early in 2009, Van den Bos et al.4 published a large
meta-analysis of results of all current treatment modali-
ties. EVLA, radio-frequency ablation (RFA) and ultrasound-
guided foam sclerotherapy (UGFS) were compared with
surgical high ligation plus stripping. As many as 64 clinical
trials that used ultrasound examination as an outcome
measure with a total of 12 320 limbs and an average follow-
up of 32.2 months were included.
After 3 years, the estimated pooled success rate was
highest after EVLA with 94%, followed by RFA (84%), surgery
(78%) and foam sclerotherapy (77%).
After adjusting for the duration of follow-up, endove-
nous laser therapy was significantly superior to all other
treatments in terms of abolition of saphenous reflux. Foam1078-5884/$36 ª 2009 European Society for Vascular Surgery. Publishe
doi:10.1016/j.ejvs.2009.09.008therapy and radio-frequency ablation were equally effec-
tive as surgery. The authors concluded that minimally
invasive techniques were ‘‘at least as effective as surgery’’
in the treatment of varicose veins.
Superior rates of abolition of saphenous reflux after
EVLA using 980-nm technology in the meta-analysis come
mostly from non-randomised trials published by enthusi-
asts of thermal ablation. Moreover, recent studies by
Proebstle et al.,5 Pannier et al.6 and others suggest that
laser light with longer wavelengths may reduce side
effects without compromising abolition of reflux. Another
recent development provides a fibre with a radial distri-
bution of laser light at its tip (Elves by Biolitec), which
may positively affect the balance between desired and
undesired effects.
RFA technology has evolved as well. RFA procedures that
were included in the meta-analysis4 used the original VNUS
Closure catheter with umbrella-shaped electrodes. They
heated the vein up to barely 90 C in a rather tedious
procedure with a slow, continuous withdrawal of the
catheter. A more recent variation (Celon by Olympus)
features bipolar radio-frequency from a sleek catheter with
two integrated electrodes that are 15-mm apart.
A further recent development is named VNUS Closure
Fast.7 The catheter’s sleek tip integrates a heating coil of
7 cm length producing temperatures up to 120 C. After
a heating cycle of 20 s, the catheter is withdrawn one step
of 6.5 cm before the next cycle begins. Large vein diame-
ters are compensated for by double dosage. One small RCT8
was published earlier this year. It suggests that Closure Fast
is superior to the conventional 980-nm laser in terms of
post-procedural recovery and quality-of-life parameters.
At Klinik Hirslanden, until last April, we have treated 155
patients with 232 refluxing saphenous veins using Closure
Fast. All procedures were carried out under tumescent
local anaesthesia only and varicose branches were removed
by hook phlebectomy in the same session. The outcomes
were examined by an independent team from the Zurich
University Hospital using questionnaires and ultrasound
examination (Amann-Vesti B. et al., publication in prepa-
ration). Among the responders (56% to date), patientd by Elsevier Ltd. All rights reserved.
98 Editorialsatisfaction with the procedure was 8.3, on average, using
a scale from 0 to 10. Furthermore, 84% of all patients were
able to return to work on the next day. Duplex ultrasound at
an average follow-up of 13.4 months confirmed abolition of
saphenous reflux in 94%. New inventions, such as steam
ablation, might find their place among other thermal
endovenous therapies in the future.
Based on some evidence from the literature and personal
experience, we believe that thermal ablation might become
a new standard for the treatment of saphenous reflux.
However, what form of thermal ablation? Techniques of the
first generation were introduced into clinical practice only
a decade ago, and it appears that continuous progress is
ongoing ever since. Present and future research may define
more clearly what temperatures are required to reach reli-
able and durable vein occlusion in combination with
a minimum of collateral damage. One might speculate that
a step-wise application of well-defined doses of energy at
moderate temperatures might improve predictability of
desired and undesired effects and the balance between
them. Notwithstanding, UGFS as an inexpensive and effective
treatment modality will play an important role, especially for
tortuous, residual and recurrent varicosities. Conventional
surgery in the form of hook phlebectomy often remains the
best way to remove varicose branches. However, the role of
high ligation and stripping as a gold standard for the treat-
ment of saphenous reflux will increasingly be questioned and
vascular surgeons are challenged to refine their surgical
procedure, for example by performing it under tumescent
anesthesia with only a small incision.
Nevertheless is it too early to define a new gold stan-
dard. There is an urgent need now for well-performed,
sufficiently large RCTs comparing occlusion rates and side
effects of surgery and recent thermal ablation technologies
in the long term, as well as safety issues and economic
viewpoints.
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